Published in Mol Cell Biol on April 23, 2007
Comprehensive Study of Post-surgical Pain After Pectus or Spine Surgery | NCT04031716
Maternal high-fat diet alters methylation and gene expression of dopamine and opioid-related genes. Endocrinology (2010) 2.02
Pain and stress in a systems perspective: reciprocal neural, endocrine, and immune interactions. J Pain (2007) 1.80
Mu opioids and their receptors: evolution of a concept. Pharmacol Rev (2013) 1.66
Chronic high-fat diet drives postnatal epigenetic regulation of μ-opioid receptor in the brain. Neuropsychopharmacology (2011) 1.34
Regulation of stress granule dynamics by Grb7 and FAK signalling pathway. EMBO J (2008) 1.27
Crh and Oprm1 mediate anxiety-related behavior and social approach in a mouse model of MECP2 duplication syndrome. Nat Genet (2012) 1.26
Epigenetic programming of mu-opioid receptor gene in mouse brain is regulated by MeCP2 and Brg1 chromatin remodelling factor. J Cell Mol Med (2008) 1.21
Up-regulation of the mu-opioid receptor gene is mediated through chromatin remodeling and transcriptional factors in differentiated neuronal cells. Mol Pharmacol (2010) 1.04
Ethnic diversity of DNA methylation in the OPRM1 promoter region in lymphocytes of heroin addicts. Hum Genet (2010) 1.00
Post-transcriptional regulation of mouse mu opioid receptor (MOR1) via its 3' untranslated region: a role for microRNA23b. FASEB J (2008) 0.98
Transcriptional and epigenetic regulation of opioid receptor genes: present and future. Annu Rev Pharmacol Toxicol (2011) 0.97
Identification of candidate genes and gene networks specifically associated with analgesic tolerance to morphine. J Neurosci (2009) 0.95
Epigenetics and the transition from acute to chronic pain. Pain Med (2012) 0.93
G protein-coupled receptors in the hypothalamic paraventricular and supraoptic nuclei--serpentine gateways to neuroendocrine homeostasis. Front Neuroendocrinol (2011) 0.92
MicroRNA 339 down-regulates μ-opioid receptor at the post-transcriptional level in response to opioid treatment. FASEB J (2012) 0.92
Increased methylation of the MOR gene proximal promoter in primary sensory neurons plays a crucial role in the decreased analgesic effect of opioids in neuropathic pain. Mol Pain (2014) 0.91
Epigenetics of drug abuse: predisposition or response. Pharmacogenomics (2012) 0.91
The protocadherins, PCDHB1 and PCDH7, are regulated by MeCP2 in neuronal cells and brain tissues: implication for pathogenesis of Rett syndrome. BMC Neurosci (2011) 0.90
Elevated levels of DNA methylation at the OPRM1 promoter in blood and sperm from male opioid addicts. J Opioid Manag (2011) 0.87
Transcriptional regulation of mouse mu opioid receptor gene in neuronal cells by poly(ADP-ribose) polymerase-1. J Cell Mol Med (2008) 0.86
p38 mitogen-activated protein kinase and PI3-kinase are involved in up-regulation of mu opioid receptor transcription induced by cycloheximide. J Neurochem (2011) 0.86
uAUG-mediated translational initiations are responsible for human mu opioid receptor gene expression. J Cell Mol Med (2009) 0.85
Differential methylation of the oxytocin receptor gene in patients with anorexia nervosa: a pilot study. PLoS One (2014) 0.84
Inhibition of c-Jun NH2-terminal kinase stimulates mu opioid receptor expression via p38 MAPK-mediated nuclear NF-κB activation in neuronal and non-neuronal cells. Biochim Biophys Acta (2013) 0.82
Post-transcriptional regulation of mu-opioid receptor: role of the RNA-binding proteins heterogeneous nuclear ribonucleoprotein H1 and F. Cell Mol Life Sci (2011) 0.82
Epigenetics of µ-opioid receptors: intersection with HIV-1 infection of the central nervous system. J Cell Physiol (2012) 0.82
Epigenetics in the perioperative period. Br J Pharmacol (2015) 0.81
A functional link between T-type calcium channels and mu-opioid receptor expression in adult primary sensory neurons. J Neurochem (2009) 0.80
Epigenetic regulation of kappa opioid receptor gene in neuronal differentiation. Neuroscience (2008) 0.80
Modulation of histone deacetylase attenuates naloxone-precipitated opioid withdrawal syndrome. Naunyn Schmiedebergs Arch Pharmacol (2012) 0.79
Vimentin interacts with the 5'-untranslated region of mouse mu opioid receptor (MOR) and is required for post-transcriptional regulation. RNA Biol (2013) 0.77
Two-hit exposure to polychlorinated biphenyls at gestational and juvenile life stages: 2. Sex-specific neuromolecular effects in the brain. Mol Cell Endocrinol (2015) 0.76
Epigenetic Activation of μ-Opioid Receptor Gene via Increased Expression and Function of Mitogen- and Stress-Activated Protein Kinase 1. Mol Pharmacol (2017) 0.75
H4K5 histone acetylation of BRG1 is associated with heroin administration rather than addiction. Exp Ther Med (2016) 0.75
Post-Transcriptional Regulation of the Human Mu-Opioid Receptor (MOR) by Morphine-Induced RNA Binding Proteins hnRNP K and PCBP1. J Cell Physiol (2016) 0.75
Don't worry; be informed about the epigenetics of anxiety. Pharmacol Biochem Behav (2016) 0.75
DNA methylation at the mu-1 opioid receptor gene (OPRM1) promoter predicts preoperative, acute, and chronic postsurgical pain after spine fusion. Pharmgenomics Pers Med (2017) 0.75
mPer1 promotes morphine-induced locomotor sensitization and conditioned place preference via histone deacetylase activity. Psychopharmacology (Berl) (2017) 0.75
A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res (2001) 124.61
Translating the histone code. Science (2001) 56.77
DNA methylation patterns and epigenetic memory. Genes Dev (2002) 33.83
Targeted mutation of the DNA methyltransferase gene results in embryonic lethality. Cell (1992) 27.80
Methylation of histone H3 lysine 9 creates a binding site for HP1 proteins. Nature (2001) 19.67
Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex. Nature (1998) 18.36
Genomic DNA methylation: the mark and its mediators. Trends Biochem Sci (2006) 13.32
Methylated DNA and MeCP2 recruit histone deacetylase to repress transcription. Nat Genet (1998) 13.27
Histone acetylation and transcriptional regulatory mechanisms. Genes Dev (1998) 10.16
DNA methylation-related chromatin remodeling in activity-dependent BDNF gene regulation. Science (2003) 8.81
Derepression of BDNF transcription involves calcium-dependent phosphorylation of MeCP2. Science (2003) 8.48
Identification and characterization of a family of mammalian methyl-CpG binding proteins. Mol Cell Biol (1998) 7.61
Analysis of the NuRD subunits reveals a histone deacetylase core complex and a connection with DNA methylation. Genes Dev (1999) 7.58
The many faces of histone lysine methylation. Curr Opin Cell Biol (2002) 6.01
Mi-2 complex couples DNA methylation to chromatin remodelling and histone deacetylation. Nat Genet (1999) 5.70
MBD2 is a transcriptional repressor belonging to the MeCP1 histone deacetylase complex. Nat Genet (1999) 5.61
Identification of a mammalian protein that binds specifically to DNA containing methylated CpGs. Cell (1989) 5.12
DNA methylation inhibits transcription indirectly via a methyl-CpG binding protein. Cell (1991) 4.90
5-Azacytidine and 5-aza-2'-deoxycytidine as inhibitors of DNA methylation: mechanistic studies and their implications for cancer therapy. Oncogene (2002) 4.81
The methyl-CpG-binding protein MeCP2 links DNA methylation to histone methylation. J Biol Chem (2002) 4.70
The thymine glycosylase MBD4 can bind to the product of deamination at methylated CpG sites. Nature (1999) 4.63
Cytosine methylation prevents binding to DNA of a HeLa cell transcription factor required for optimal expression of the adenovirus major late promoter. Genes Dev (1988) 4.02
Retinoic acid induces embryonal carcinoma cells to differentiate into neurons and glial cells. J Cell Biol (1982) 3.85
Methyl-CpG binding protein MBD1 couples histone H3 methylation at lysine 9 by SETDB1 to DNA replication and chromatin assembly. Mol Cell (2004) 3.60
Methylation of CpG sequences in eukaryotic DNA. FEBS Lett (1981) 3.39
DNA methylation specifies chromosomal localization of MeCP2. Mol Cell Biol (1996) 3.10
Control of muscle and neuronal differentiation in a cultured embryonal carcinoma cell line. Nature (1982) 3.05
DNA binding selectivity of MeCP2 due to a requirement for A/T sequences adjacent to methyl-CpG. Mol Cell (2005) 3.01
Opioid-receptor mRNA expression in the rat CNS: anatomical and functional implications. Trends Neurosci (1995) 3.00
Dependence of transcriptional repression on CpG methylation density. Mol Cell Biol (1994) 2.97
Molecular mechanisms and regulation of opioid receptor signaling. Annu Rev Pharmacol Toxicol (2000) 2.95
The p120 catenin partner Kaiso is a DNA methylation-dependent transcriptional repressor. Genes Dev (2001) 2.91
Histone H3 lysine 4 methylation disrupts binding of nucleosome remodeling and deacetylase (NuRD) repressor complex. J Biol Chem (2002) 2.89
P19 embryonal carcinoma cells. Int J Dev Biol (1993) 2.71
Epigenetic marks by DNA methylation specific to stem, germ and somatic cells in mice. Genes Cells (2002) 2.52
Chromatin compaction by human MeCP2. Assembly of novel secondary chromatin structures in the absence of DNA methylation. J Biol Chem (2003) 2.14
Methyl CpG-binding proteins and transcriptional repression. Bioessays (2001) 2.03
Valproate induces replication-independent active DNA demethylation. J Biol Chem (2003) 2.02
Comparison of in vitro and in vivo reference genes for internal standardization of real-time PCR data. Biotechniques (2006) 1.91
The role of nuclear factor kappaB in tumor necrosis factor-regulated transcription of the human mu-opioid receptor gene. Mol Pharmacol (2003) 1.73
Methyl-CpG binding domain 1 (MBD1) interacts with the Suv39h1-HP1 heterochromatic complex for DNA methylation-based transcriptional repression. J Biol Chem (2003) 1.71
The cell-specific expression of endothelial nitric-oxide synthase: a role for DNA methylation. J Biol Chem (2004) 1.56
DNA methylation is linked to deacetylation of histone H3, but not H4, on the imprinted genes Snrpn and U2af1-rs1. Mol Cell Biol (2001) 1.55
Somatic frameshift mutations in the MBD4 gene of sporadic colon cancers with mismatch repair deficiency. Oncogene (1999) 1.55
An embarrassment of niches: the many covalent modifications of histones in transcriptional regulation. Oncogene (2001) 1.46
Opioid tolerance-in search of the holy grail. Cell (2002) 1.46
Genomic structure and chromosomal mapping of the murine and human Mbd1, Mbd2, Mbd3, and Mbd4 genes. Mamm Genome (1999) 1.44
The expression of endothelial nitric-oxide synthase is controlled by a cell-specific histone code. J Biol Chem (2005) 1.44
Regulation of mu opioid receptor mRNA levels by activation of protein kinase C in human SH-SY5Y neuroblastoma cells. Anesthesiology (1997) 1.40
Genomic structure analysis of promoter sequence of a mouse mu opioid receptor gene. Proc Natl Acad Sci U S A (1994) 1.34
De novo DNA methyltransferases Dnmt3a and Dnmt3b primarily mediate the cytotoxic effect of 5-aza-2'-deoxycytidine. Oncogene (2005) 1.32
Mammalian methyltransferases and methyl-CpG-binding domains: proteins involved in DNA methylation. Curr Top Microbiol Immunol (2000) 1.31
Methylation-dependent silencing at the H19 imprinting control region by MeCP2. Nucleic Acids Res (2002) 1.25
A role of N-cadherin in neuronal differentiation of embryonic carcinoma P19 cells. Biochem Biophys Res Commun (2001) 1.25
Differentiation and maturation of embryonal carcinoma-derived neurons in cell culture. J Neurosci (1988) 1.20
Oxygen-regulated erythropoietin gene expression is dependent on a CpG methylation-free hypoxia-inducible factor-1 DNA-binding site. Eur J Biochem (1998) 1.14
Neuron-restrictive silencer factor (NRSF) functions as a repressor in neuronal cells to regulate the mu opioid receptor gene. J Biol Chem (2004) 1.13
CpG sites preferentially methylated by Dnmt3a in vivo. J Biol Chem (2006) 1.09
Transcriptional regulation of mouse mu-opioid receptor gene. J Biol Chem (1998) 1.06
Wnt-1 promotes neuronal differentiation and inhibits gliogenesis in P19 cells. Biochem Biophys Res Commun (2002) 1.06
Developmental expression of the mu, kappa, and delta opioid receptor mRNAs in mouse. J Neurosci (1998) 1.06
Dual promoters of mouse mu-opioid receptor gene. Biochem Biophys Res Commun (1997) 1.05
Evidence of the neuron-restrictive silencer factor (NRSF) interaction with Sp3 and its synergic repression to the mu opioid receptor (MOR) gene. Nucleic Acids Res (2006) 1.04
Transcriptional regulation of mouse mu opioid receptor gene by PU.1. J Biol Chem (2004) 1.03
Mouse mu opioid receptor distal promoter transcriptional regulation by SOX proteins. J Biol Chem (2002) 1.03
The interleukin-1beta-mediated regulation of proenkephalin and opioid receptor messenger RNA in primary astrocyte-enriched cultures. Neuroscience (1997) 0.99
Transcriptional regulation of mouse mu opioid receptor gene: Sp3 isoforms (M1, M2) function as repressors in neuronal cells to regulate the mu opioid receptor gene. Mol Pharmacol (2005) 0.98
Sox6 overexpression causes cellular aggregation and the neuronal differentiation of P19 embryonic carcinoma cells in the absence of retinoic acid. FEBS Lett (2004) 0.96
Retinoic acid-induced chromatin remodeling of mouse kappa opioid receptor gene. J Neurosci (2005) 0.95
Differential promoter usage of mouse mu-opioid receptor gene during development. Brain Res Mol Brain Res (2002) 0.92
The prenatal development profile of expression of opioid peptides and receptors in the mouse brain. Brain Res Dev Brain Res (1991) 0.91
DNA methylation-related chromatin modification in the regulation of mouse delta-opioid receptor gene. Mol Pharmacol (2005) 0.89
An intronic Ikaros-binding element mediates retinoic acid suppression of the kappa opioid receptor gene, accompanied by histone deacetylation on the promoters. J Biol Chem (2000) 0.87
Transient upregulation of mu opioid receptor mRNA levels in nucleus accumbens during chronic cocaine administration. Can J Physiol Pharmacol (1998) 0.87
Expression of mu-, kappa- and delta-opioid receptors in P19 mouse embryonal carcinoma cells. Neuroscience (1999) 0.86
Ecotropic viral integration site-1 is activated during, and is sufficient for, neuroectodermal P19 cell differentiation. Cell Growth Differ (1999) 0.86
Ectopic expression of Axin blocks neuronal differentiation of embryonic carcinoma P19 cells. J Biol Chem (2003) 0.85
Evidence for kappa- and mu-opioid receptor expression in C6 glioma cells. J Neurochem (1998) 0.85
Regulation of mu-opioid receptor mRNA in rat globus pallidus: effects of enkephalin increases induced by short- and long-term haloperidol administration. J Neurochem (1994) 0.83
Actions of endotoxin and morphine. Adv Exp Med Biol (2001) 0.82
Molecular cloning and functional analysis of the rat mu opioid receptor gene promoter. Biochem Biophys Res Commun (1995) 0.81
Induction of the mouse kappa-opioid receptor gene by retinoic acid in P19 cells. J Biol Chem (2002) 0.81
Morphine upregulates mu opioid receptors of human and monkey lymphocytes. Biochem Biophys Res Commun (2000) 0.79
mu-Opioid receptor gene expression: the role of NCAM. Neuroscience (2001) 0.79
Probing protein oligomerization in living cells with fluorescence fluctuation spectroscopy. Proc Natl Acad Sci U S A (2003) 3.02
Opioid-induced tolerance and dependence in mice is modulated by the distance between pharmacophores in a bivalent ligand series. Proc Natl Acad Sci U S A (2005) 2.29
Unidirectional cross-activation of GRPR by MOR1D uncouples itch and analgesia induced by opioids. Cell (2011) 2.13
Beta-arrestin-dependent mu-opioid receptor-activated extracellular signal-regulated kinases (ERKs) Translocate to Nucleus in Contrast to G protein-dependent ERK activation. Mol Pharmacol (2007) 1.56
MicroRNA mir-346 targets the 5'-untranslated region of receptor-interacting protein 140 (RIP140) mRNA and up-regulates its protein expression. Biochem J (2009) 1.49
NF-κB-mediated degradation of the coactivator RIP140 regulates inflammatory responses and contributes to endotoxin tolerance. Nat Immunol (2012) 1.48
Agonist-selective signaling is determined by the receptor location within the membrane domains. Proc Natl Acad Sci U S A (2008) 1.36
Axonal mRNA transport and localized translational regulation of kappa-opioid receptor in primary neurons of dorsal root ganglia. Proc Natl Acad Sci U S A (2006) 1.35
Suppression of receptor interacting protein 140 repressive activity by protein arginine methylation. EMBO J (2006) 1.34
Mu-opioid receptors modulate the stability of dendritic spines. Proc Natl Acad Sci U S A (2005) 1.34
Heterodimerization of mu- and delta-opioid receptors occurs at the cell surface only and requires receptor-G protein interactions. J Biol Chem (2005) 1.34
Spinal G-protein-gated potassium channels contribute in a dose-dependent manner to the analgesic effect of mu- and delta- but not kappa-opioids. J Neurosci (2005) 1.33
Inhibition of PI3K/Akt signaling: an emerging paradigm for targeted cancer therapy. Curr Med Chem Anticancer Agents (2005) 1.32
Thyroid hormone-induced juxtaposition of regulatory elements/factors and chromatin remodeling of Crabp1 dependent on MED1/TRAP220. Mol Cell (2005) 1.30
Regulation of stress granule dynamics by Grb7 and FAK signalling pathway. EMBO J (2008) 1.27
Mu-opioid receptor desensitization: role of receptor phosphorylation, internalization, and representation. J Biol Chem (2003) 1.25
Application of rpoB and zinc protease gene for use in molecular discrimination of Fusobacterium nucleatum subspecies. J Clin Microbiol (2009) 1.25
The adaptor Grb7 links netrin-1 signaling to regulation of mRNA translation. EMBO J (2007) 1.21
Epigenetic programming of mu-opioid receptor gene in mouse brain is regulated by MeCP2 and Brg1 chromatin remodelling factor. J Cell Mol Med (2008) 1.21
Adenylyl cyclase superactivation induced by long-term treatment with opioid agonist is dependent on receptor localized within lipid rafts and is independent of receptor internalization. Mol Pharmacol (2006) 1.21
Regulation of co-repressive activity of and HDAC recruitment to RIP140 by site-specific phosphorylation. Mol Cell Proteomics (2005) 1.21
Poly(C)-binding proteins as transcriptional regulators of gene expression. Biochem Biophys Res Commun (2009) 1.20
Post-translational modifications of nuclear co-repressor RIP140: a therapeutic target for metabolic diseases. Curr Med Chem (2008) 1.19
Morphine-induced mu-opioid receptor rapid desensitization is independent of receptor phosphorylation and beta-arrestins. Cell Signal (2008) 1.19
Uric acid-induced phenotypic transition of renal tubular cells as a novel mechanism of chronic kidney disease. Am J Physiol Renal Physiol (2013) 1.18
Morphine regulates dopaminergic neuron differentiation via miR-133b. Mol Pharmacol (2010) 1.18
mu-Opioid receptor agonists differentially regulate the expression of miR-190 and NeuroD. Mol Pharmacol (2009) 1.18
Cholesterol regulation of receptor-interacting protein 140 via microRNA-33 in inflammatory cytokine production. FASEB J (2011) 1.18
Unraveling protein-protein interactions in living cells with fluorescence fluctuation brightness analysis. Biophys J (2005) 1.16
A negative regulatory pathway of GLUT4 trafficking in adipocyte: new function of RIP140 in the cytoplasm via AS160. Cell Metab (2009) 1.16
Assembly of a beta2-adrenergic receptor--GluR1 signalling complex for localized cAMP signalling. EMBO J (2009) 1.16
Regulation of opioid receptor expression. Curr Opin Pharmacol (2002) 1.16
Agonist-selective signaling of G protein-coupled receptor: mechanisms and implications. IUBMB Life (2010) 1.14
Neuron-restrictive silencer factor (NRSF) functions as a repressor in neuronal cells to regulate the mu opioid receptor gene. J Biol Chem (2004) 1.13
Modulation of lysine acetylation-stimulated repressive activity by Erk2-mediated phosphorylation of RIP140 in adipocyte differentiation. Cell Signal (2008) 1.13
Distinct effects of individual opioids on the morphology of spines depend upon the internalization of mu opioid receptors. Mol Cell Neurosci (2007) 1.12
Poly(C) binding protein family is a transcription factor in mu-opioid receptor gene expression. Mol Pharmacol (2005) 1.11
Rewarding effects of ethanol and cocaine in mu opioid receptor-deficient mice. Naunyn Schmiedebergs Arch Pharmacol (2002) 1.11
Yin Yang 1 phosphorylation contributes to the differential effects of mu-opioid receptor agonists on microRNA-190 expression. J Biol Chem (2010) 1.11
Retinoic acid-stimulated sequential phosphorylation, PML recruitment, and SUMOylation of nuclear receptor TR2 to suppress Oct4 expression. Proc Natl Acad Sci U S A (2008) 1.10
Palmitoylation and membrane cholesterol stabilize μ-opioid receptor homodimerization and G protein coupling. BMC Cell Biol (2012) 1.10
Netrin-1 signaling regulates de novo protein synthesis of kappa opioid receptor by facilitating polysomal partition of its mRNA. J Neurosci (2006) 1.08
Cytoplasmic receptor-interacting protein 140 (RIP140) interacts with perilipin to regulate lipolysis. Cell Signal (2011) 1.08
Lysine trimethylation of retinoic acid receptor-alpha: a novel means to regulate receptor function. Mol Cell Proteomics (2007) 1.08
PKCepsilon stimulated arginine methylation of RIP140 for its nuclear-cytoplasmic export in adipocyte differentiation. PLoS One (2008) 1.07
Post-transcriptional regulation of opioid receptors in the nervous system. Front Biosci (2004) 1.06
Mouse kappa-opioid receptor mRNA differential transport in neurons. Mol Pharmacol (2003) 1.05
Up-regulation of the mu-opioid receptor gene is mediated through chromatin remodeling and transcriptional factors in differentiated neuronal cells. Mol Pharmacol (2010) 1.04
Evidence of the neuron-restrictive silencer factor (NRSF) interaction with Sp3 and its synergic repression to the mu opioid receptor (MOR) gene. Nucleic Acids Res (2006) 1.04
Long-term morphine treatment decreases the association of mu-opioid receptor (MOR1) mRNA with polysomes through miRNA23b. Mol Pharmacol (2009) 1.04
Vitamin B6 conjugation to nuclear corepressor RIP140 and its role in gene regulation. Nat Chem Biol (2007) 1.04
Copb1-facilitated axonal transport and translation of kappa opioid-receptor mRNA. Proc Natl Acad Sci U S A (2007) 1.03
Transcriptional regulation of mouse mu opioid receptor gene by PU.1. J Biol Chem (2004) 1.03
Novel function of the poly(C)-binding protein alpha CP3 as a transcriptional repressor of the mu opioid receptor gene. FASEB J (2007) 1.03